Sulforaphane reverses glucocorticoid-induced apoptosis in osteoblastic cells through regulation of the Nrf2 pathway

References

• Hsu WL Chen CY Tsauo JY Yang RS Balance control in elderly people with osteoporosis J Formos Med Assoc 2014 113 6 334 339 24650494
   PubMed Web of Science ®Google Scholar
• Reid IR Anti-resorptive therapies for osteoporosis Semin Cell Dev Biol 2008 19 5 473 478 18760372
   PubMed Web of Science ®Google Scholar
• Salam SN Eastell R Khwaja A Fragility fractures and osteoporosis in CKD: pathophysiology and diagnostic methods Am J Kidney Dis 2014 S0272 6386 14 499 495 24631043
   PubMed Web of Science ®Google Scholar
• Seibel MJ Cooper MS Zhou H Glucocorticoid-induced osteoporosis: mechanisms, management, and future perspectives Lancet Diabetes Endocrinol 2013 1 1 59 70 24622268
   PubMed Web of Science ®Google Scholar
• Brennan-Speranza TC Henneicke H Gasparini SJ Osteoblasts mediate the adverse effects of glucocorticoids on fuel metabolism J Clin Invest 2012 122 11 4172 4189 23093779
   PubMed Web of Science ®Google Scholar
• Rauch A Seitz S Baschant U Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor Cell Metab 2010 11 6 517 531 20519123
   PubMed Web of Science ®Google Scholar
• den Uyl D Bultink IE Lems WF Advances in glucocorticoid-induced osteoporosis Curr Rheumatol Rep 2011 13 3 233 240 21365209
   PubMed Web of Science ®Google Scholar
• Weinstein RS Clinical practice. Glucocorticoid-induced bone disease N Engl J Med 2011 365 1 62 70 21732837
   PubMed Web of Science ®Google Scholar
• Espina B Liang M Russell RG Hulley PA Regulation of Bim in glucocorticoid-mediated osteoblast apoptosis J Cell Physiol 2008 215 2 488 496 18064628
   PubMed Web of Science ®Google Scholar
• O’Brien CA Jia D Plotkin LI Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength Endocrinology 2004 145 4 1835 1841 14691012
   PubMed Web of Science ®Google Scholar
• Yun SI Yoon HY Jeong SY Chung YS Glucocorticoid induces apoptosis of osteoblast cells through the activation of glycogen synthase kinase 3beta J Bone Miner Metab 2009 27 2 140 148 19066717
   PubMed Web of Science ®Google Scholar
• Choi EM Kim GH Lee YS Protective effects of dehydrocostus lactone against hydrogen peroxide-induced dysfunction and oxidative stress in osteoblastic MC3T3-E1 cells Toxicol In Vitro 2009 23 5 862 867 19457452
   PubMed Web of Science ®Google Scholar
• Wang Y Wang WL Xie WL Puerarin stimulates proliferation and differentiation and protects against cell death in human osteoblastic MG-63 cells via ER-dependent MEK/ERK and PI3K/Akt activation Phytomedicine 15 2013 20 10 787 796 23639192
   PubMed Web of Science ®Google Scholar
• Yan XT Lee SH Li W Evaluation of the antioxidant and anti-osteoporosis activities of chemical constituents of the fruits of Prunus mume Food Chem 2014 156 408 415 24629988
   PubMed Web of Science ®Google Scholar
• Zhang JK Yang L Meng GL Protective effect of tetrahydroxystilbene glucoside against hydrogen peroxide-induced dysfunction and oxidative stress in osteoblastic MC3T3-E1 cells Eur J Pharmacol 2012 689 1–3 31 37 22683865
   PubMed Web of Science ®Google Scholar
• Wiseman M The second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective Proc Nutr Soc 2008 67 3 253 256 18452640
   PubMed Web of Science ®Google Scholar
• Gupta P Kim B Kim SH Srivastava SK Molecular targets of isothiocyanates in cancer: recent advances Mol Nutr Food Res Epub 2 10 2014
   Web of Science ®Google Scholar
• Houghton CA Fassett RG Coombes JS Sulforaphane: translational research from laboratory bench to clinic Nutr Rev 2013 71 11 709 726 24147970
   PubMed Web of Science ®Google Scholar
• Xu T Ren D Sun X Yang G Dual roles of sulforaphane in cancer treatment Anticancer Agents Med Chem 2012 12 9 1132 1142 22583415
   PubMed Web of Science ®Google Scholar
• Tarozzi A Angeloni C Malaguti M Morroni F Hrelia S Hrelia P Sulforaphane as a potential protective phytochemical against neurodegenerative diseases Oxid Med Cell Longev 2013 2013 415078 23983898
   PubMed Web of Science ®Google Scholar
• Barcelo S Gardiner JM Gescher A Chipman JK CYP2E1-mediated mechanism of anti-genotoxicity of the broccoli constituent sulforaphane Carcinogenesis 1996 17 2 277 282 8625450
   PubMed Web of Science ®Google Scholar
• Gross-Steinmeyer K Stapleton PL Tracy JH Bammler TK Strom SC Eaton DL Sulforaphane- and phenethyl isothiocyanate-induced inhibition of aflatoxin B1-mediated genotoxicity in human hepatocytes: role of GSTM1 genotype and CYP3A4 gene expression Toxicol Sci 2010 116 2 422 432 20442190
   PubMed Web of Science ®Google Scholar
• Katoch O Kumar A Adhikari JS Dwarakanath BS Agrawala PK Sulforaphane mitigates genotoxicity induced by radiation and anticancer drugs in human lymphocytes Mutat Res 2013 758 1–2 29 34 24004877
   PubMed Web of Science ®Google Scholar
• Fan C Chen J Wang Y Selenocystine potentiates cancer cell apoptosis induced by 5-fluorouracil by triggering reactive oxygen species-mediated DNA damage and inactivation of the ERK pathway Free Radic Biol Med 2013 65 305 316 23837948
   PubMed Web of Science ®Google Scholar
• Su J Lai H Chen J Natural borneol, a monoterpenoid compound, potentiates selenocystine-induced apoptosis in human hepatocellular carcinoma cells by enhancement of cellular uptake and activation of ROS-mediated DNA damage PLoS One 2013 8 5 e63502 23700426
   PubMed Web of Science ®Google Scholar
• McIlwain DR Berger T Mak TW Caspase functions in cell death and disease Cold Spring Harb Perspect Biol 2013 5 4 a008656 23545416
   PubMed Web of Science ®Google Scholar
• Xu ZS Wang XY Xiao DM Hydrogen sulfide protects MC3T3-E1 osteoblastic cells against H2O2-induced oxidative damage-implications for the treatment of osteoporosis Free Radic Biol Med 2011 50 10 1314 1323 21354302
   PubMed Web of Science ®Google Scholar
• Nakashima K Zhou X Kunkel G The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation Cell 2002 108 1 17 29 11792318
   PubMed Web of Science ®Google Scholar
• Komori T Regulation of osteoblast differentiation by transcription factors J Cell Biochem 2006 99 5 1233 1239 16795049
   PubMed Web of Science ®Google Scholar
• Arai M Shibata Y Pugdee K Abiko Y Ogata Y Effects of reactive oxygen species (ROS) on antioxidant system and osteoblastic differentiation in MC3T3-E1 cells IUBMB Life 2007 59 1 27 33 17365177
   PubMed Web of Science ®Google Scholar
• Kansanen E Kuosmanen SM Leinonen H Levonen AL The Keap1-Nrf2 pathway: mechanisms of activation and dysregulation in cancer Redox Biol 2013 1 1 45 49 24024136
   PubMed Web of Science ®Google Scholar
• Seeman E Delmas PD Bone quality: the material and structural basis of bone strength and fragility N Engl J Med 2006 354 21 2250 2261 16723616
   PubMed Web of Science ®Google Scholar
• Lee NK Choi YG Baik JY A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation Blood 2005 106 3 852 859 15817678
   PubMed Web of Science ®Google Scholar